1650 |
Moderate-intensity Statin + Ezetimibe versus High-intensity Statin Monotherapy in ASCVD: RACING Trial |
Myeong-Ki Hong |
Apr. 20. 23 |
1649 |
Intravascular Imaging–Guided or Angiography-Guided Complex PCI: RENOVATE-COMPLEX-PCI |
Joo-Yong Hahn |
Apr. 20. 23 |
1648 |
FFR vs. IVUS to Guide PCI |
Bon-Kwon Koo |
Apr. 20. 23 |
1647 |
Valvular and Perivalvular Thrombosis After TAVR: ADAPT-TAVR Cardiac CT Substudy |
Yeonwoo Choi |
Apr. 20. 23 |
1646 |
Early Percutaneous Mitral Commissurotomy or Conventional Management for Asymptomatic Mitral Stenosis: A Randomised Clinical Trial |
Duk-Hyun Kang |
Apr. 20. 23 |
1645 |
Prognostic Role of Routine Stress Testing in Diabetic Patients After PCI: Key Analysis from POST-PCI |
Hoyun Kim |
Apr. 20. 23 |
1644 |
Effect of OMT on Long-Term (10-Yr) Outcomes After Myocardial Revascularization |
Jinsun Park |
Apr. 20. 23 |
1643 |
Prognostic Impact of Mildly Impaired Renal Function After Multivessel Revascularization |
Tae-Oh Kim |
Apr. 20. 23 |
1642 |
Racial Differences of Prosthesis-Patient Mismatch After TAVR |
Hanbit Park |
Apr. 20. 23 |
1641 |
Inter-Racial Differences in Characteristics and Outcomes After TAVR: TP-TAVR Registry |
Do-Yoon Kang |
Apr. 20. 23 |